11-103316544-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001080463.2(DYNC2H1):c.11671-1G>A variant causes a splice acceptor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000287 in 1,395,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001080463.2 splice_acceptor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYNC2H1 | NM_001080463.2 | c.11671-1G>A | splice_acceptor_variant | ENST00000650373.2 | NP_001073932.1 | |||
DYNC2H1 | NM_001377.3 | c.11650-1G>A | splice_acceptor_variant | ENST00000375735.7 | NP_001368.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYNC2H1 | ENST00000375735.7 | c.11650-1G>A | splice_acceptor_variant | 1 | NM_001377.3 | ENSP00000364887 | P3 | |||
DYNC2H1 | ENST00000650373.2 | c.11671-1G>A | splice_acceptor_variant | NM_001080463.2 | ENSP00000497174 | A1 | ||||
DYNC2H1 | ENST00000334267.11 | c.2206-119399G>A | intron_variant | 1 | ENSP00000334021 | |||||
DYNC2H1 | ENST00000528670.5 | c.829-1G>A | splice_acceptor_variant, NMD_transcript_variant | 5 | ENSP00000433451 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000287 AC: 4AN: 1395038Hom.: 0 Cov.: 30 AF XY: 0.00000145 AC XY: 1AN XY: 688130
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Mar 13, 2015 | - - |
Jeune thoracic dystrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | This sequence change affects an acceptor splice site in intron 80 of the DYNC2H1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in DYNC2H1 are known to be pathogenic (PMID: 23339108, 32753734, 33755199). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DYNC2H1-related conditions. ClinVar contains an entry for this variant (Variation ID: 235270). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at